Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19

August 25, 2020Press Releases

Bioscience firm applies AI and data science to identify existing drugs Atozet and Cablivi as potentially effective therapies for blood clots and inflammation caused by COVID-19 CHARLOTTESVILLE, Va., Aug. 25, 2020 /PRNewswire/ — Two newly repositioned drugs with the potential to combat key symptoms of COVID-19 were announced today by Biovista, an AI-driven bioscience firm that … Read More

Mechanistic analysis of Atorvastatin

June 19, 2020COVID-19, Vizit Graphs

Repositioning of Atorvastatin for the treatment of COVID-19. Statins such as Atorvastatin are potent cholesterol-lowering drugs that are tested against COVID-19. Statins could be proven beneficial particularly against SARS-CoV-2-induced cardiovascular manifestations. Explore the live graph.

Mechanistic analysis of combination IFB-a2b chlorpheniramine, ibuprofen

June 19, 2020COVID-19, Vizit Graphs

Chlorphenamine is a known antihistamine used to treat the symptoms of allergic conditions such as allergic rhinitis, whereas Ibuprofen is a potent nonsteroidal anti-inflammatory drug (NSAID). Combination of Chlorpheniramine and ibuprofen combination have long been postulated to treat common cold and its symptoms. Role and efficacy in the COVID-19 remains to be elucidated. Explore the … Read More